Not applicableLooking for participantsNCT06526442What this trial is testingMRE for Diagnosis of Pancreatic MassesWho this might be right forPancreatic NeoplasmMagnetic Resonance Imaging Yu Shi 200
Testing effectiveness (Phase 2)Looking for participantsNCT04485286What this trial is testingEvaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue InjuryWho this might be right forLung CancerRadiation FibrosisRadiation Induced Lung Injury+1 more Massachusetts General Hospital 72
Not applicableStudy completedNCT04931069What this trial is testingCorrelation Between Complications After Pancreaticoduodenectomy and MicrobiotaWho this might be right forPancreatic Cancer University Hospital, Toulouse 39
Not applicableActive Not RecruitingNCT05038254What this trial is testingEnhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse EventsWho this might be right forClinical Stage IV Esophageal Adenocarcinoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+42 more M.D. Anderson Cancer Center 750
Not applicableStudy completedNCT03918759What this trial is testingDiagnostic Accuracy of Preoperative Diagnostic Procedure in the Assessment of Lymph Node Metastases by NF-PanNENsWho this might be right forNon Functioning Pancreatic Endocrine Tumor IRCCS San Raffaele 100
Testing effectiveness (Phase 2)Study completedNCT01053013What this trial is testingOpen-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal CancerWho this might be right forPancreatic Adenocarcinoma Non-resectablePancreatic Adenocarcinoma MetastaticColorectal Cancer Metastatic The Rogosin Institute 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT05669482What this trial is testingStudy of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic CancerWho this might be right forKRAS Activating MutationMetastatic CancerPancreas Cancer+2 more Verastem, Inc. 40
Testing effectiveness (Phase 2)Ended earlyNCT04659603What this trial is testingTusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid TumorsWho this might be right forBreast Cancer MetastaticPancreatic Carcinoma Metastatic Sanofi 50
Post-approval studies (Phase 4)WithdrawnNCT03891979What this trial is testingGut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic AdenocarcinomaWho this might be right forPancreatic Cancer NYU Langone Health
Large-scale testing (Phase 3)Ended earlyNCT04592861What this trial is testingCarbon Ion RT for Locally Advanced Pancreatic CancerWho this might be right forPancreatic Cancer Albert Einstein College of Medicine 5
Not applicableLooking for participantsNCT06585072What this trial is testingPancreatic Cancer and Diabetes MellitusWho this might be right forPancreatic CancerSurgeryDiabetes Mellitus Shanghai Changzheng Hospital 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT06381154What this trial is testingPhotoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic CancerWho this might be right forLocally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage II Pancreatic Cancer AJCC v8+3 more Mayo Clinic 24
Very early researchStudy completedNCT02295956What this trial is testingPreoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic CancerWho this might be right forPancreatic Cancer M.D. Anderson Cancer Center 75
Not applicableEnded earlyNCT01872377What this trial is testingDose Escalation Study of CyberKnife® SBRT Boost for Patients With Unresectable Locally Advanced Pancreatic CancerWho this might be right forPancreatic Carcinoma Non-resectable Ottawa Hospital Research Institute 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT06188702What this trial is testingS095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAPWho this might be right forMTAP-deleted Solid Tumors Servier Bio-Innovation LLC 60
Testing effectiveness (Phase 2)Study completedNCT05795595What this trial is testingA Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid TumorsWho this might be right forClear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)UnknownNCT05218629What this trial is testingAnlotinib Plus PD-1 Inhibitor as 2nd-line Threapy in Patients With Metastatic Pancreatic CancerWho this might be right forOverall Survival Qingdao Central Hospital 20
Large-scale testing (Phase 3)Study completedNCT00003029What this trial is testingFluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the PancreasWho this might be right forPancreatic Cancer European Organisation for Research and Treatment of Cancer - EORTC 200
Not applicableStudy completedNCT04609137What this trial is testingEarly Drain Removal Versus Standard Drain Management After Distal Pancreatectomy (Early-Dist)Who this might be right forPancreas DiseaseComplication,PostoperativePROMs+1 more IRCCS San Raffaele 150
Testing effectiveness (Phase 2)Study completedNCT05031494What this trial is testingAssess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with CancersWho this might be right forMelanomaPancreatic Ductal Adenocarcinoma Eucure (Beijing) Biopharma Co., Ltd 40